A thoughtful look at whether sober reason deserves its status as the surest path to truth.
Western philosophy has often trusted sober, rational thought as the surest route to truth, leaving dreams, hallucinations and psychedelic states at the edges.

Psychedelics, treated with care and context.
The Psychedelic Podcast treats psychedelics as medicine, philosophy, culture, and lived experience. Its interviews move carefully from personal stories into questions of safety, access, ecology, faith, embodiment, and the limits of ordinary consciousness.
PRESS PLAY
The Psychedelic Podcast covers the psychedelic field as a meeting place for medicine, philosophy, spirituality, culture, and practical care. It moves slowly enough for complexity to stay intact. Recent episodes look at altered states not only as therapeutic tools, but as challenges to inherited ideas about reality, truth, body awareness, community, and moral responsibility. In a conversation with Justin Smith Ruiu, the show considers why Western philosophy has often treated waking, sober reason as the preferred route to truth. That inquiry opens onto dreams, hallucinations, language, contradiction, and the difficulty of describing experiences that do not behave like ordinary thought. Other episodes stay closer to clinical life. Melissa Bond describes benzodiazepine dependence in physical, cognitive, and maternal terms, while Dr. Amy De La Garza helps frame how low-dose ketamine and other psychedelic approaches are being discussed around withdrawal and recovery. The show does not treat medical novelty as a shortcut. Its interviews repeatedly return to preparation, safety, screening, integration, and support after the peak experience has passed. A discussion with Dr. Jeffrey Gerst shifts the lens to sourcing and scale, asking whether psychedelic compounds can be produced in ways that are lower cost and less damaging to fragile ecosystems. That practical concern sits beside a broader unease about patents, access, and who gets to benefit from new treatments. Jonathan Dickinson's episode on ibogaine brings similar questions into addiction, traumatic brain injury, neurological care, traditional Bwiti practice, and the infrastructure required for responsible treatment. Christopher Solomon's salvia conversation reframes an often sensationalized substance through somatic awareness, breath, pacing, and careful container building. Jodi Lomask brings a creative vocabulary, connecting immersive performance, nature-based experience, group agreements, and flow states. Hunt Priest's episode considers psychedelics through contemplative Christianity, institutional pressure, justice, and spiritual formation. Across these conversations, Paul Austin tends to begin broadly, restate the guest's point, then widen the frame. The show is warm without becoming loose. It is earnest without flattening disagreement. Its best moments come when a personal account becomes a larger pattern, or when a technical question becomes an ethical one. For listeners following psychedelic research, therapy, faith, embodiment, and policy, it offers a broad but grounded map of a fast-changing field.
Made for: For listeners interested in psychedelic research, therapy, consciousness, spirituality, and policy who prefer patient interviews over hype. It especially suits people who want clinical, philosophical, and lived-experience perspectives in the same feed.
What sets it apart: The show stands out by holding therapeutic promise and cultural risk in the same conversation. It gives room to clinicians, writers, entrepreneurs, guides, artists, and faith leaders while returning often to safety, access, preparation, and integration.
The Psychedelic Podcast connects you to the leaders and pioneers of the psychedelic renaissance. From deep healing to creativity, leadership to spirituality, business, health, human performance, relationships, sexuality, and even culture itself—every aspect of our world is being transformed by psychedelic medicines. Get an inspired, informed, balanced look into how these powerful medicines are already being safely and responsibly used to catalyze both personal and collective transformation. Whether you're just curious or a seasoned psychonaut, or somewhere in between, you'll get insightful, practical, cutting-edge conversations from the forefront of the psychedelic movement. Join us as we ex…
Based on 6 episodes we listened to · September 2026
Wide-ranging interviews connect psychedelic health claims to personal experience, clinical practice, spiritual life, ecological limits, and questions of access.
Paul Austin treats psychedelics as a health question with unusually wide borders. His guest-led conversations move from bioengineered compounds and sustainable sourcing to benzodiazepine withdrawal, childhood trauma, Christian contemplative practice, technology, and Western…
Bioengineered yeast gets a seat at Paul Austin's table; your ethics committee may want one too.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A thoughtful look at whether sober reason deserves its status as the surest path to truth.
Western philosophy has often trusted sober, rational thought as the surest route to truth, leaving dreams, hallucinations and psychedelic states at the edges.
Melissa Bond makes benzodiazepine withdrawal vivid, while Dr. Amy De La Garza adds context on recovery and ketamine's still-emerging role.
Benzodiazepine dependence lands with unusual clarity through Melissa Bond's account of interdose withdrawal, with medication taken at night leaving her in withdrawal by morning or afternoon.
A measured look at scaling psychedelic medicine while keeping ecosystems, access, and corporate power in view.
The Psychedelic Podcast looks at a pressure point in psychedelic medicine: demand is rising, while the ecosystems and harvesting practices behind some compounds remain fragile. Dr.
Jodi Lamasque makes a thoughtful case for creativity, setting and group respect as active parts of psychedelic experience.
Jodi Lamasque approaches psychedelic experiences as something designed, rather than simply taken. Drawing on decades of immersive performance through Capacitor, she considers how creativity, embodiment and setting shape the process.
Hunt Priest ties a 2016 clergy study to Christian mysticism, institutional conflict, and the moral pressure of spiritual conviction.
The Psychedelic Podcast takes on a charged and unusually personal question: what changes when a Christian minister makes psychedelics part of his spiritual life in public?
A shift from Adobe to psychedelic practice frames a careful look at using technology without being ruled by it.
Technology can look like the natural opponent of spiritual practice, but this PlayNext episode finds a more interesting middle ground. Its subject moves from product management at Adobe into psychedelic work, with stops in startup life and prep and integration coaching.
A candid account of ayahuasca, childhood trauma, forgiveness, and the work of living out personal change.
Natalie Baird-King's story follows a successful family law attorney and certified mediator through depression, burnout, alcohol dependence, and an ayahuasca retreat in Costa Rica that reshaped how she talks about childhood trauma and forgiveness.


Careful conversations on drugs, treatment, and recovery.

Buddhist practice for the predictive brain.

Long conversations with people who think in systems.

Behavioural science with a commercial pulse.

Sharper tools for harder medical work.
Lana Pribic discusses how iboga and kanna, two African plants, facilitate deep inner transformation and truth revelation, contrasting them with classic psychedelics.
Natalie Baird-King, a Florida family law attorney, shares how ayahuasca helped her heal from childhood abuse by her father.
Host Paul interviews Tonia Erin, who transitioned from an 11-year product manager role at Adobe to a psychedelic practitioner after personal psychedelic experiences.
A conversation with Justin Smith-Ruiu about how Western philosophy has historically excluded altered states of consciousness and what psychedelic experiences reveal about the nature of reality.
Melissa Bond and Dr.
Dr.
Shaahin Cheyene discusses creating Herbal Ecstasy as a teenager, sparking the legal smart drug movement amid the 1990s rave scene and MDMA shortage.
Jonathan Dickinson discusses Ibogaine's potential for treating traumatic brain injury and addiction, bridging traditional Bwiti practice with modern clinical models.
Christopher Solomon discusses the therapeutic potential of salvia divinorum when used with somatic awareness and structured intention.
Jodi Lomask, founder of Capacitor and an artist-in-residence at UCSF Neuroscape Lab, frames psychedelics as "creative design" rather than therapy alone.
Hunt Priest says the Episcopal Church told him to choose between Ligare and ordination.
Paul Austin answers audience questions about microdosing protocols, performance vs healing, and psychedelic integration in a bonus AMA episode.
Brian Robertson discusses his psychedelic church Ledgeway Sangha, which uses a non-doctrinal, peer-to-peer model for healing with subtle psychedelics.
Dr.